Genewiz launched Gene Synthesis 2.0, upgrading how researchers design and order genes through a faster, packaged ordering experience and updated codon optimization. The platform includes Sprint, Flex, and Flex+ options, enabling design workflows such as cloning strategy selection, sequence complexity assessment, and ordering in minutes. Genewiz also introduced enhanced codon optimization that blends established heuristics with machine-learning models trained on a high-expression dataset, aiming to improve expression reliability while keeping user control over design choices. The rollout targets workflows in antibody discovery, AI-enabled biology, and gene and cell therapy—areas where design-to-execution speed can directly affect iteration cycles.